MTOR and breast cancer: Xuaet al. reported that miRNAs are involved in the regulation of chemoresistance to ovarian cancer, colorectal cancer, non‐small cell lung cancer or breast cancer by targeting mTOR/P70S6K1 and MAP/ERK kinase kinase 1 (MEKK1), among others.